These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
377 related articles for article (PubMed ID: 26548532)
1. Expression of LMP and EBNA genes in Epstein-Barr virus-associated lymphomas in Hu-PBL/SCID mice. Tang Y; Lu S; Gan X; Liu F; Zhang Y; Luo C; Pan Y; Hong L; Gan R Oncol Rep; 2016 Feb; 35(2):905-11. PubMed ID: 26548532 [TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter. Jiménez-Ramírez C; Brooks AJ; Forshell LP; Yakimchuk K; Zhao B; Fulgham TZ; Sample CE J Virol; 2006 Nov; 80(22):11200-8. PubMed ID: 16956945 [TBL] [Abstract][Full Text] [Related]
3. Identification of IgH gene rearrangement and immunophenotype in an animal model of Epstein-Barr virus-associated lymphomas. Zhang Y; Peng X; Tang Y; Gan X; Wang C; Xie L; Xie X; Gan R; Wu Y J Med Virol; 2016 Oct; 88(10):1804-13. PubMed ID: 26991077 [TBL] [Abstract][Full Text] [Related]
4. Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells. Rasul AE; Nagy N; Sohlberg E; Ádori M; Claesson HE; Klein G; Klein E J Immunol Methods; 2012 Nov; 385(1-2):60-70. PubMed ID: 22921685 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese. Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607 [TBL] [Abstract][Full Text] [Related]
6. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques. Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452 [TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells. Allday MJ; Crawford DH; Thomas JA J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171 [TBL] [Abstract][Full Text] [Related]
9. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas. Xu ZG; Iwatsuki K; Oyama N; Ohtsuka M; Satoh M; Kikuchi S; Akiba H; Kaneko F Br J Cancer; 2001 Apr; 84(7):920-5. PubMed ID: 11286472 [TBL] [Abstract][Full Text] [Related]
10. [Expression of Epstein-Barr virus genes in EBV-associated gastric carcinoma]. Wang Y; Luo B; Zhao P; Huang BH Ai Zheng; 2004 Jul; 23(7):782-7. PubMed ID: 15248912 [TBL] [Abstract][Full Text] [Related]
11. Construction of hu-PBL/SCID chimeras and development of EBV-related lymphomas. Gan RL; Lan K; Yin ZH; Wang LJ; Song Y; Yao KT Chin Med Sci J; 2005 Mar; 20(1):16-22. PubMed ID: 15844306 [TBL] [Abstract][Full Text] [Related]
12. EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines. Chen A; Zhao B; Kieff E; Aster JC; Wang F J Virol; 2006 Oct; 80(20):10139-50. PubMed ID: 17005691 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency. Hamilton-Dutoit SJ; Rea D; Raphael M; Sandvej K; Delecluse HJ; Gisselbrecht C; Marelle L; van Krieken HJ; Pallesen G Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003 [TBL] [Abstract][Full Text] [Related]
14. Epstein-barr virus (EBV) in healthy carriers: Distribution of genotypes and 30 bp deletion in latent membrane protein-1 (LMP-1) oncogene. Correa RM; Fellner MD; Alonio LV; Durand K; Teyssié AR; Picconi MA J Med Virol; 2004 Aug; 73(4):583-8. PubMed ID: 15221903 [TBL] [Abstract][Full Text] [Related]
15. Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site. Zhao B; Sample CE J Virol; 2000 Jun; 74(11):5151-60. PubMed ID: 10799590 [TBL] [Abstract][Full Text] [Related]
16. [Studies on transforming functions of Epstein-Barr virus-specific proteins]. Kinoshita T Hokkaido Igaku Zasshi; 1990 Jul; 65(4):362-75. PubMed ID: 2172130 [TBL] [Abstract][Full Text] [Related]
17. Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1. Kis LL; Takahara M; Nagy N; Klein G; Klein E Immunol Lett; 2006 Apr; 104(1-2):83-8. PubMed ID: 16386314 [TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. Wang F; Gregory C; Sample C; Rowe M; Liebowitz D; Murray R; Rickinson A; Kieff E J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887 [TBL] [Abstract][Full Text] [Related]
19. IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines. Kis LL; Takahara M; Nagy N; Klein G; Klein E Blood; 2006 Apr; 107(7):2928-35. PubMed ID: 16332968 [TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. Deacon EM; Pallesen G; Niedobitek G; Crocker J; Brooks L; Rickinson AB; Young LS J Exp Med; 1993 Feb; 177(2):339-49. PubMed ID: 8381153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]